CY1124010T1 - Μια φαρμακευτικη συνθεση για την παρεμποδιση της διατροφικης παχυσαρκιας - Google Patents
Μια φαρμακευτικη συνθεση για την παρεμποδιση της διατροφικης παχυσαρκιαςInfo
- Publication number
- CY1124010T1 CY1124010T1 CY20211100251T CY211100251T CY1124010T1 CY 1124010 T1 CY1124010 T1 CY 1124010T1 CY 20211100251 T CY20211100251 T CY 20211100251T CY 211100251 T CY211100251 T CY 211100251T CY 1124010 T1 CY1124010 T1 CY 1124010T1
- Authority
- CY
- Cyprus
- Prior art keywords
- obesity
- prevention
- pharmaceutical composition
- mixture
- nutritional
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title abstract 4
- 235000020824 obesity Nutrition 0.000 title abstract 4
- 235000016709 nutrition Nutrition 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 4
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 abstract 4
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201721029447 | 2017-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1124010T1 true CY1124010T1 (el) | 2022-05-27 |
Family
ID=63244444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20211100251T CY1124010T1 (el) | 2017-08-19 | 2021-03-23 | Μια φαρμακευτικη συνθεση για την παρεμποδιση της διατροφικης παχυσαρκιας |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10702487B2 (pt) |
| EP (1) | EP3443987B1 (pt) |
| BR (1) | BR102018016746A8 (pt) |
| CA (1) | CA3012675C (pt) |
| CY (1) | CY1124010T1 (pt) |
| DK (1) | DK3443987T3 (pt) |
| EA (1) | EA201891651A3 (pt) |
| ES (1) | ES2864136T3 (pt) |
| HR (1) | HRP20210466T1 (pt) |
| HU (1) | HUE053678T2 (pt) |
| LT (1) | LT3443987T (pt) |
| MY (1) | MY177974A (pt) |
| PH (1) | PH12018000207A1 (pt) |
| PL (1) | PL3443987T3 (pt) |
| PT (1) | PT3443987T (pt) |
| RS (1) | RS61628B1 (pt) |
| SG (1) | SG10201806472SA (pt) |
| SI (1) | SI3443987T1 (pt) |
| UA (1) | UA122710C2 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021041495A2 (en) * | 2019-08-26 | 2021-03-04 | The Trustees Of Indiana University | Method to maintain or enhance tissue |
| CN111084301B (zh) * | 2019-12-30 | 2023-08-22 | 内江师范学院 | 一种桑叶提取物鱼饲料粘合剂及制备方法和应用 |
| CN113712206A (zh) * | 2021-09-16 | 2021-11-30 | 湖南希尔天然药业有限公司 | 一种含有桑叶dnj和桑叶肽的组合物及其制备方法 |
| AU2022416432A1 (en) * | 2021-12-13 | 2024-07-25 | The Regents Of The University Of California | Method of treating liver steatosis with bioavailable formulation of oleoylethanolamide |
| WO2023250211A2 (en) * | 2022-06-24 | 2023-12-28 | Veroscience Llc | Treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4042687A (en) * | 1975-11-24 | 1977-08-16 | Control Drug, Inc. | Method of treating obesity by the oral administration of a predigested protein composition |
| CN1523982A (zh) | 2001-03-27 | 2004-08-25 | ���������Ǵ�ѧ���»� | 减少体脂和调节脂肪酸代谢的方法、化合物和组合物 |
| US20050054730A1 (en) * | 2001-03-27 | 2005-03-10 | The Regents Of The University Of California | Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha |
| WO2004034968A2 (en) | 2002-08-20 | 2004-04-29 | The Regents Of The University Of California | Combination therapy for controlling appetites |
| WO2004045307A2 (en) | 2002-11-18 | 2004-06-03 | Natural Asa | Dietry supplements and foods product comprising oleylethanolamide |
| WO2004078113A2 (en) | 2003-03-04 | 2004-09-16 | Pharmacia Corporation | Treatment and prevention of obesity with cox-2 inhibitors alone or in combination with weight-loss agents |
| CA2542547A1 (en) | 2003-10-16 | 2005-05-26 | Daniele Piomelli | Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism |
| WO2007006319A2 (en) | 2005-07-14 | 2007-01-18 | Rheoscience A/S | Inhibitors of anorexic lipid hydrolysis for the treatment of eating disorders |
| WO2009093737A1 (ja) * | 2008-01-25 | 2009-07-30 | Kobayashi Pharmaceutical Co., Ltd. | 抗肥満用医薬組成物 |
| WO2009142713A1 (en) | 2008-05-19 | 2009-11-26 | Nestec S.A. | Methods for reducing lipid absorption by an animal |
| RU2583435C2 (ru) | 2010-07-28 | 2016-05-10 | Те Риджентс Оф Те Юниверсити Оф Калифорния | Ингибиторы faah периферически-ограниченного действия |
| WO2012090225A2 (en) | 2010-12-29 | 2012-07-05 | Nutracryst Therapeutics Private Limited | Novel cocrystals / molecular salts of metformin with oleoylethanolamide as an effective anti-diabetic + anti- obesity agent |
| MX2013013098A (es) | 2011-05-10 | 2013-12-16 | Nestec Sa | Metodos y composiciones para fomentar el crecimiento de la masa corporal magra. |
| CN104203906B (zh) | 2011-08-19 | 2018-03-13 | 加利福尼亚大学董事会 | 间位取代的联苯基外周限制性faah抑制剂 |
| CN102579414A (zh) | 2012-01-29 | 2012-07-18 | 厦门大学 | 油酰乙醇胺作为降血脂、防治非酒精性脂肪肝药物的用途 |
| RS57146B1 (sr) | 2012-07-24 | 2018-07-31 | Bial Portela & Ca Sa | Jedinjenja uree i njihova upotreba kao inhibitora enzima |
| CN104602536A (zh) | 2012-09-07 | 2015-05-06 | 雀巢产品技术援助有限公司 | 油酰乙醇胺组合物 |
| ITMI20131180A1 (it) | 2013-07-15 | 2015-01-16 | Fond Istituto Italiano Di Tecnologia | O-alchil triazolil carbammati come inibitori di idrolasi delle ammidi degli acidi grassi (faah) |
| JP6390874B2 (ja) | 2013-07-18 | 2018-09-19 | フォンダツィオーネ・イスティテュート・イタリアーノ・ディ・テクノロジア | フェニルカルバメート並びに脂肪酸アミドヒドロラーゼ（ｆａａｈ）酵素の阻害剤及びｄ３ドーパミン受容体（ｄ３ｄｒ）の調節剤としてのその使用 |
| EP3024825B1 (en) | 2013-07-24 | 2017-06-21 | BIAL - PORTELA & Cª, S.A. | Imidazolecarboxamides and their use as faah inhibitors |
| JP2016528227A (ja) | 2013-08-01 | 2016-09-15 | ビアル−ポルテラ エ コンパニア，ソシエダッド アノニマ | ウレア化合物および酵素阻害剤としてのそれらの使用 |
| WO2015157313A1 (en) | 2014-04-07 | 2015-10-15 | The Regents Of The University Of California | Inhibitors of fatty acid amide hydrolase (faah) enzyme with improved oral bioavailability and their use as medicaments |
| IL305528A (en) | 2015-05-21 | 2023-10-01 | Scisparc Ltd | Combinations of opioids and acylethnoamines |
| CN108348468A (zh) | 2015-08-11 | 2018-07-31 | Eyesiu医疗股份有限公司 | 具有生物活性亲脂性化合物的聚乙二醇化脂质纳米粒 |
-
2018
- 2018-07-26 US US16/046,482 patent/US10702487B2/en active Active
- 2018-07-27 CA CA3012675A patent/CA3012675C/en active Active
- 2018-07-27 MY MYPI2018702652A patent/MY177974A/en unknown
- 2018-07-30 SG SG10201806472SA patent/SG10201806472SA/en unknown
- 2018-07-31 PH PH12018000207A patent/PH12018000207A1/en unknown
- 2018-08-13 EP EP18188634.2A patent/EP3443987B1/en active Active
- 2018-08-13 PT PT181886342T patent/PT3443987T/pt unknown
- 2018-08-13 PL PL18188634T patent/PL3443987T3/pl unknown
- 2018-08-13 SI SI201830245T patent/SI3443987T1/sl unknown
- 2018-08-13 LT LTEP18188634.2T patent/LT3443987T/lt unknown
- 2018-08-13 RS RS20210359A patent/RS61628B1/sr unknown
- 2018-08-13 DK DK18188634.2T patent/DK3443987T3/da active
- 2018-08-13 HU HUE18188634A patent/HUE053678T2/hu unknown
- 2018-08-13 ES ES18188634T patent/ES2864136T3/es active Active
- 2018-08-16 BR BR102018016746A patent/BR102018016746A8/pt active IP Right Grant
- 2018-08-16 UA UAA201808780A patent/UA122710C2/uk unknown
- 2018-08-16 EA EA201891651A patent/EA201891651A3/ru unknown
-
2021
- 2021-03-19 HR HRP20210466TT patent/HRP20210466T1/hr unknown
- 2021-03-23 CY CY20211100251T patent/CY1124010T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201891651A3 (ru) | 2019-05-31 |
| UA122710C2 (uk) | 2020-12-28 |
| EP3443987A1 (en) | 2019-02-20 |
| DK3443987T3 (da) | 2021-03-22 |
| EA201891651A2 (ru) | 2019-02-28 |
| ES2864136T3 (es) | 2021-10-13 |
| US10702487B2 (en) | 2020-07-07 |
| SG10201806472SA (en) | 2019-03-28 |
| BR102018016746A2 (pt) | 2019-03-26 |
| EP3443987B1 (en) | 2020-12-23 |
| CA3012675C (en) | 2021-06-15 |
| RS61628B1 (sr) | 2021-04-29 |
| PH12018000207B1 (en) | 2019-06-03 |
| HRP20210466T1 (hr) | 2021-05-14 |
| BR102018016746A8 (pt) | 2023-02-14 |
| CA3012675A1 (en) | 2019-02-19 |
| US20190054046A1 (en) | 2019-02-21 |
| LT3443987T (lt) | 2021-04-26 |
| PL3443987T3 (pl) | 2021-08-02 |
| PH12018000207A1 (en) | 2019-06-03 |
| HUE053678T2 (hu) | 2021-07-28 |
| PT3443987T (pt) | 2021-03-18 |
| SI3443987T1 (sl) | 2021-07-30 |
| MY177974A (en) | 2020-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124010T1 (el) | Μια φαρμακευτικη συνθεση για την παρεμποδιση της διατροφικης παχυσαρκιας | |
| SG10201907660YA (en) | Use of short chain fatty acids in cancer prevention | |
| BR112015017322A2 (pt) | composição flavorizante e composições comestíveis contendo a mesma | |
| EA201792562A1 (ru) | Глюкагон и коагонисты гпп-1 | |
| MX2019001903A (es) | Composiciones y metodos para modular la microflora gastrointestinal en un canino. | |
| BR112017025339A2 (pt) | composições nutricionais contendo um nível elevado de inositol e usos das mesmas | |
| CY1117209T1 (el) | Συνθεσεις περιλαμβανοντας 15-ηερε και μεθοδοι χρησης των ιδιων | |
| DOP2022000229A (es) | Anticuerpos de cadena pesada multiespecíficos con regiones constantes de cadena pesada modificadas | |
| CO2020010193A2 (es) | Una composición farmacéutica para la anemia | |
| CL2022002963A1 (es) | Anticuerpos de cadena pesada multiespecíficos con regiones constantes de cadena pesada modificadas | |
| BR112018008186A2 (pt) | métodos que utilizam proteína de soro de leite para melhorar ou manter a qualidade muscular | |
| BR112017026241A2 (pt) | composições farmacêuticas e alimentícias para induzir a saciação e prolongar a saciedade em indivíduos que necessitem das mesmas | |
| CL2017000475A1 (es) | Composición para formulación cosmética que consiste en una mezcla de hasta 3 componentes seleccionados de manteca de murumuru, manteca de ucuuba, aceite de nuez de brasil, aceite de maracuyá, manteca de copoazú, aceite de acai y aceite de andiroba y/o ésteres de los mismos; producto cosmético. | |
| EA033540B1 (ru) | Композиция, включающая окру, для применения в уменьшении абсорбции пищевого жира | |
| EA201791531A1 (ru) | Натуральный подсластитель | |
| BR112017007066A2 (pt) | composições e métodos para melhorar a mobilidade ou a atividade, ou tratar a debilidade | |
| MX2017006639A (es) | Metodos y composiciones para preservar la masa corporal magra y promover la perdida de grasa durante la perdida de peso. | |
| UY36663A (es) | Anticuerpos anti-ap2 y agentes de unión al antígeno para tratar trastornos metabólicos | |
| EA201790535A1 (ru) | Композиция, которая модифицирует вкусоароматические качества, ее применение и продукты, которые ее содержат | |
| EA201891592A1 (ru) | Основанная на пищевых продуктах доставка терапевтического агента для лечения печеночной энцефалопатии | |
| BR112014032478A2 (pt) | nanogel compreendendo ingredientes ativos solúveis em água | |
| MX2017006638A (es) | Metodos y composiciones para el incremento de la masa corporal magra y minimizar la ganancia de grasa corporal y el control del peso. | |
| BR112017013650A2 (pt) | processo e concentrado para a fabricação de uma pré-mistura | |
| CL2018000023A1 (es) | Polvo de chocolate aglomerado soluble | |
| WO2016073326A3 (en) | Methods and compositions for treating and preventing arthritis |